Unlocking the Power of Natural Killer
Cell Therapeutics

Precision Stem Cell Engineering to Unlock the Power of NK Cells

“We are excited to collaborate with Cellectis, a gene-editing pioneer and leader in the de

Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress

June 10th, 2022

See All News & Events

The Power of Combining iPSC-Derived NK Cell Therapy & NK Cell Engager Antibodies
(Cell & Gene Therapy Insights)

August 1st, 2022

IPSCs For Democratized Cell Therapy
(BioProcess Online)

June 7th, 2022

What's New at Cytovia